Capricor Therapeutics (CAPR) Shares Outstanding (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Shares Outstanding (Entity) of $57.7 million for Q1 2026, up 26.24% year-over-year from $45.7 million in Q1 2025, and up 24.07% quarter-over-quarter from $46.5 million in Q4 2025.
Capricor Therapeutics (CAPR) Shares Outstanding (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $57.7 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 26.24% year-over-year to $57.7 million; the TTM figure through Mar 2026 stood at $57.7 million (up 26.24% YoY), while the FY2025 annual figure was $46.5 million, up 31.97% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $57.7 million, up from $46.5 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $57.7 million in Q1 2026, with the low at $24.3 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $31.6 million (2024), against an average of $34.1 million.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) climbed 2.29% in 2022, then jumped 44.55% in 2025.
- Capricor Therapeutics' Shares Outstanding (Entity) stood at $25.2 million in 2022, then increased by 23.4% to $31.1 million in 2023, then gained by 13.07% to $35.2 million in 2024, then jumped by 31.97% to $46.5 million in 2025, then climbed by 24.07% to $57.7 million in 2026.
- Business Quant data shows CAPR's Shares Outstanding (Entity) at $57.7 million in Q1 2026, $46.5 million in Q4 2025, and $45.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | 57.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.43 Mn |
| Dec 31, 2025 | 46.48 Mn |
| Sep 30, 2025 | 45.72 Mn |
| Jun 30, 2025 | 45.71 Mn |
| Mar 31, 2025 | 45.64 Mn |
| Dec 31, 2024 | 35.22 Mn |
| Sep 30, 2024 | 33.09 Mn |
| Jun 30, 2024 | 31.84 Mn |
| Mar 31, 2024 | 31.35 Mn |
| Dec 31, 2023 | 26.78 Mn |
| Sep 30, 2023 | 25.82 Mn |
| Jun 30, 2023 | 25.34 Mn |
| Mar 31, 2023 | 25.25 Mn |
| Dec 31, 2022 | 24.55 Mn |
| Sep 30, 2022 | 24.43 Mn |
| Jun 30, 2022 | 24.32 Mn |
| Mar 31, 2022 | 24.28 Mn |
| Dec 31, 2021 | 23.09 Mn |
| Sep 30, 2021 | 23.10 Mn |
| Jun 30, 2021 | 22.86 Mn |